Tong Jiefeng, M.S. Med

Department:Hematology

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Associate Chief Physician


Appointment

Clinical / Research Interests

Dr. Tong has been engaged in the clinical diagnosis and treatment, teaching and scientific research of hematological diseases for many years, and has rich clinical experience in the diagnosis and treatment of hematological malignancies such as lymphoma, multiple myeloma, leukemia, hematopoietic stem cell transplantation, and the diagnosis and treatment of various anemia and cytopenia. She is especially good at applying molecular targeted therapy, biological immunotherapy, CAR-T cell therapy and hematopoietic stem cell transplantation in the precision treatment of recurrent refractory lymphoma. 

Professional Highlights

High Quality PBL Case Award, Zhejiang University School of Medicine, Third Prize, 2023 

Excellent Teacher, SAHZU, 2020

Advanced Worker, SAHZU, 2017


Professional Appointments

Education Experience

Master Degree, Zhejiang University School of Medicine, 1998-2002

Research Summary

Publications

Zhang L, Tong J, He X, Liang Y, Zhu L, Xu R, Zhao X. Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells. Annals of Hematology. 2018 Dec;97:2353-62.

Tong J, Hu R, Zhao Y, Xu Y, Zhao X, Jin X. Serum vitamin A levels may affect the severity of ocular graft-versus-host disease. Frontiers in Medicine. 2017 Jun 22;4:67.

Current Program

Accurate diagnosis (MICM) and standardized individualized treatment of non-Hodgkin's lymphoma in adults. Funding Source: Zhejiang Provincial Major Science and Technology Projects (NO. 2009C03012-4), 2009-2013.

Find People

Search by Family Name

Find A Department

Search by Departments